Ⅲ型前膠原氨基端原肽(PIIINP)卵白蛋白偶聯(lián)物
OVA Conjugated Procollagen III N-Terminal Propeptide (PIIINP)
P3NP; N-Propeptide Of Type III Procollagen; Procollagen III Amino Terminal Propeptide
- 編號(hào)CPA573Hu21
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來(lái)源蛋白偶聯(lián)
- 原分子量-
- 緩沖液成份磷酸鹽緩沖液（pH7.4）
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)-
- 應(yīng)用Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 806¥ 2016¥ 4032¥ 12096¥ 30240
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Mass spectrometry
SDS-PAGE圖
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
化學(xué)式
用法
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA573Hu02 | Ⅲ型前膠原氨基端原肽(PIIINP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA573Hu62 | Ⅲ型前膠原氨基端原肽(PIIINP)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA573Hu63 | Ⅲ型前膠原氨基端原肽(PIIINP)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA573Hu01 | Ⅲ型前膠原氨基端原肽(PIIINP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA573Hu61 | Ⅲ型前膠原氨基端原肽(PIIINP)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA573Hu61 | Ⅲ型前膠原氨基端原肽(PIIINP)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPA573Hu21 | Ⅲ型前膠原氨基端原肽(PIIINP)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| SPA573Hu02 | Ⅲ型前膠原氨基端原肽(PIIINP)合成多肽 | Immunogen; Blocking Peptide. |
| CPA573Hu22 | Ⅲ型前膠原氨基端原肽(PIIINP)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| CPA573Hu31 | Ⅲ型前膠原氨基端原肽(PIIINP)鑰孔血藍(lán)蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| SPA573Hu01 | Ⅲ型前膠原氨基端原肽(PIIINP)合成多肽 | Immunogen; Blocking Peptide. |
| SPA573Hu71 | Ⅲ型前膠原氨基端原肽(PIIINP)合成多肽 | Immunogen; Blocking Peptide. |
| PAA573Hu01 | Ⅲ型前膠原氨基端原肽(PIIINP)多克隆抗體 | WB; IHC |
| PAA573Hu02 | Ⅲ型前膠原氨基端原肽(PIIINP)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA573Hu09 | Ⅲ型前膠原氨基端原肽(PIIINP)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA573Hu08 | Ⅲ型前膠原氨基端原肽(PIIINP)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA573Hu71 | Ⅲ型前膠原氨基端原肽(PIIINP)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA573Hu23 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | WB; IHC |
| MAA573Hu24 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | WB; IHC |
| MAA573Hu27 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | WB; IHC; ICC/IF |
| MAA573Hu28 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | WB |
| MAA573Hu26 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | IHC; FCM |
| MAA573Hu29 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | WB |
| MAA573Hu25 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | WB |
| MAA573Hu21 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | WB; IHC |
| MAA573Hu22 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | WB; IHC |
| FAA573Hu04 | 抗Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | Flow cytometry. |
| FAA573Hu08 | 抗Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | Flow cytometry. |
| FAA573Hu06 | 抗Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | Flow cytometry. |
| FAA573Hu02 | 抗Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體 | Flow cytometry. |
| LAA573Hu94 | Ⅲ型前膠原氨基端原肽(PIIINP)單克隆抗體(辣根過(guò)氧化物酶標(biāo)記) | IHC; ICC |
| HEA573Hu | Ⅲ型前膠原氨基端原肽(PIIINP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEA573Hu | Ⅲ型前膠原氨基端原肽(PIIINP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CEA573Hu | Ⅲ型前膠原氨基端原肽(PIIINP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA573Hu | Ⅲ型前膠原氨基端原肽(PIIINP)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSA573Hu01 | Ⅲ型前膠原氨基端原肽(PIIINP)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA573Hu11 | Ⅲ型前膠原氨基端原肽(PIIINP)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
| KSA573Hu01 | Ⅲ型前膠原氨基端原肽(PIIINP)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動(dòng)手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Molecular Biology Reports | Characterization of the specific and sustained GH1 expression induced by rAAV2/1 in normal adult male rats[PubMed: 20204528] |
| Obesity Surgery | A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis[PubMed: 20532833] |
| Liver Biopsy | Comparison of Five Liver Fibrosis Indexes with Serum Levels of Laminin and N Terminal Peptide of Procollagen Type III in Chronic Hepatitis Patients[Intechopen: 18785] |
| Trials | Is there benefit in optimising heart failure treatment in over-80 year-old patients? (HF-80 study): study protocol for a randomized controlled trial.[Trials: 1745-6215] |
| American Journal of Hypertension | Aliskiren and Perindopril Reduce the Levels of Transforming Growth Factor-β in Patients With Non-Diabetic Kidney Disease[Nature: 201214] |
| Arthritis Research and Therapy | Raised circulating tenascin-C in rheumatoid arthritis.[PubMed: 23193984] |
| American Heart Journal | Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.[PubMed: 23067911] |
| hepatology research | Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B.[PubMed: 22734888] |
| Digestive and Liver Disease | Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial[Pubmed: 23238034] |
| Journal of Infectious Diseases | Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis[Pubmed: 23922364] |
| International Urogynecology Journal | Prevalence, etiology and risk factors of pelvic organ prolapse in premenopausal primiparous women[Springer: Source] |
| Journal of Clinical and Experimental Hepatology | Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioacetamide-induced Rat Liver Fibrosis[ScienceDirect: S0973688314000073] |
| Der Urologe | Retroperitoneale Fibrose[Springer:Source] |
| Ultrasound in Obstetrics & Gynecology | The status of the pelvic floor in young primiparous women[Wiley:Source] |
| PLoS One. | Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease[Pubmed:24603967] |
| Clin Chim Acta. | Serum and urinary procollagen III aminoterminal propeptide as a biomarker of obstructive nephropathy in children[Pubmed:24768785] |
| BMC Gastroenterol. | Fast food diet with CCl4 micro-dose induced hepatic-fibrosis-a novel animal model[Pubmed:24884574] |
| Toxicology. | DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2[Pubmed:24945829] |
| Southeast Asian J Trop Med Public Health. | Correlation of HBsAg titers with serum fibrotic maker in patients with chronic hepatitis B infection.[Pubmed:24974647] |
| The American Journal of Cardiology | Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease[Pubmed:25073565] |
| Ann Rheum Dis. | B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease[Pubmed:25143523] |
| Scientific Reports | Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension[PubMed: 25747153] |
| Int J Mol Sci | The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension[PubMed: 25984599] |
| Viral Hepatitis Journal | The Relationship of the Degree of Hepatic Fibrosis with Hyaluronic Acid, Type 4 Collagen, and Procollagen Type 3 N-Terminal Peptide Levels in Patients with Chronic Viral Hepatitis[Openview: 8A0B8C97D72C61741371F33508760B75] |
| International Journal of Experimental Pathology | Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet[doi:10.1111] |
| Heart Rhythm.? | Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population[Pubmed:26776557] |
| BMJ Open Sport Exerc Med | Procollagen markers in microdialysate can predict patient outcome after Achilles tendon rupture[content:2] |
| Inflammation Research | Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy[pubmed:27516211] |
| Heart & Vessels | Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR[pubmed:28004175] |
| american journal of physiology-renal physiology | Extracellular microRNA signature in chronic kidney disease.[pubmed:28077372] |
| Cellular?Physiology and Biochemistry | Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy[pubmed:27889753] |
| PLoS One. | Procollagen?C-Proteinase?Enhancer?1?(PCPE-1) as a?Plasma?Marker?of?Muscleand?Liver Fibrosis?in?Mice.[pubmed:27458976] |
| International?Journal?of?Cardiology | 5-methoxytryptophan?is a?potential?marker?for?post-myocardial?infarction?heart?failure - apreliminary?approach?to?clinical?utility.[pubmed:27526355] |
| Transplant Proc | Urinary Type III Procollagen Is Associated With Chronic Allograft Dysfunction and Predicts Graft Survival.[pubmed:28219585] |
| Knee Surg Sports Traumatol Arthrosc | Achilles tendon rupture healing is enhanced by intermittent pneumatic compression upregulating collagen type I synthesis[pubmed:28668970] |
| Antiviral Therapy | Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study[pubmed:28054933] |
| Molecular?Medicine?Reports | Profilin?1 contributes to cardiac injury induced by advanced glycation end?products in rats[pubmed:28901418] |
| Biomarkers Medicial | Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellitus[pubmed:28685602] |
| Heart and Vessels | Left ventricular reverse remodeling is not related to biopsy?detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR[10.1007/s00380-016-0930-y] |
| Clinical Infectious Diseases | Matrix Degradation in Human Immunodeficiency Virus Type 1–Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study[10.1093/cid/cix231] |
| Cytokine | 12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis.[pubmed:28460256] |
| Advanced Healthcare Materials | Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events.[pubmed:29120858] |
| American Journal of?Kidney?Diseases | Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders[Pubmed:29602632] |
| Angiology | The Association of Biomarkers of Inflammation and Extracellular Matrix Degradation With the Risk of Abdominal Aortic Aneurysm: The ARIC Study[article:10.1007] |
| Hernia | Circulating matrix metalloproteinases and procollagen propeptides in inguinal hernia[Pubmed:29484522] |
| Cardiovascular Journal of Africa | Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.[Pubmed:29443354] |
| Turk Kardiyol Dern Ars.? | Association between reverse electrical remodeling and cardiac fibrosis markers in patients with cardiac resynchronization therapy[Pubmed:29512624] |
| Кардиоваскулярная терапия и профилактика | N-терминальный пропептид проколлагена III типа в качестве возможного сывороточного маркера фиброза миокарда у больных сахарным диабетом 2?…[:] |
| Clinical?Infectious?Diseases | Improvement in Hepatic Fibrosis Biomarkers Associated with Chemokine Receptor Inactivation through Mutation or Therapeutic Blockade[Pubmed: 30239650] |
| Anatolian Journal of Cardiology | microRNA-29a inhibits cardiac fibrosis in Sprague-Dawley rats by downregulating the expression of DNMT3A.[Pubmed: 30297596] |
| Contemporary?Clinical?Trials | Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design[Doi: 10.1016/j.cct.2018.10.012] |
| Arthritis?Research &?Therapy | Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease[Pubmed: 30547825] |
| American Journal of Respiratory and?Critical?Care?Medicine | Identification and Modulation of Microenvironment is Crucial for Effective MSC Therapy in Acute Lung Injury[Pubmed: 30521764] |
| Direktor: Prof. Dr. med. Andreas Mügge[] | |
| Scientific Reports | Low fibrosis biomarker levels predict cardiac resynchronization therapy response[Pubmed: 30988339] |
| American Journal of Translational Research | Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype[Pubmed: 30972180] |
| Food and Chemical Toxicology | Gum Acacia mitigates diclofenac nephrotoxicity by targeting monocyte chemoattractant protein-1, complement receptor-1 and pro-apoptotic pathways[Pubmed: 31042592] |
| Digestive diseases and sciences | Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index[Pubmed: 31468264] |
| Journal of Diabetes Research | Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis[Pubmed: 33224989] |
| BMC GASTROENTEROLOGY | Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy[Pubmed: 33069226] |
| european heart journal | A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial[Pubmed: 32578850] |
| Ассоциации толщины эпикардиального жира и циркулирующих маркеров фиброза миокарда у пациентов с инфарктом миокарда[] | |
| J Am Geriatr Soc | Association of Non?\Steroidal Anti?\Inflammatory Drugs with Kidney Health in Ambulatory Older Adults[33305369] |
| Aging (Albany NY) | Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after??-[33431713] |
| PeerJ | Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial[33614272] |
| Open Forum Infectious Diseases | Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis[34104667] |
| European Heart Journal | A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes[32578850] |
| Nutrients | The Effect of Daily Methylsulfonylmethane (MSM) Consumption on High-Density Lipoprotein Cholesterol in Healthy Overweight and Obese Adults: A Randomized?…[34684621] |
| J Diabetes Res | Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus[34778465] |
| Scandinavian Cardiovascular Journal | Dual integrin αvβ3 and αvβ5 blockade attenuates cardiac dysfunction by reducing fibrosis in a rat model of doxorubicin-induced cardiomyopathy[34296634] |
| J. Clin. Med | Simple Predictors for Cardiac Fibrosis in Patients with Type 2 Diabetes Mellitus: The Role of Circulating Biomarkers and Pulse Wave Velocity[Pubmed:35628969] |
| Biomolecules | Increase in Serum MMP-9 and TIMP-1 Concentrations during Alcohol Intoxication in Adolescents—A Preliminary Study[Pubmed:35625637] |